SCHEMBL2592406

SCHEMBL2592406

Oc1ncccc1-c1cccnc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 9/20 0.57
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP1A2 P05177 1/20 0.56
KDM4E B2RXH2 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MKNK1 Q9BUB5 1/20 0.47
MKNK2 Q9HBH9 1/20 0.47
NUDT1 P36639 1/20 0.46
CYP11B1 P15538 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29709996 0.83 ALDH1A1 (0.50) CYP2A6ALDH1A1L3MBTL1LMNAHPGD
SCHEMBL8526461 0.83 ALDH1A1 (0.50) CYP2A6ALDH1A1L3MBTL1LMNAHPGD
SCHEMBL20541087 0.80 CYP2A6 (0.70) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E
SCHEMBL30026143 0.80 CYP2A6 (0.70) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E
SCHEMBL2592408 0.79 TDP1 (0.44) ALDH1A1CYP3A4KDM4EL3MBTL1LMNA
SCHEMBL28181896 0.79 PTGS2 (0.64) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E
SCHEMBL31635952 0.79 PTGS2 (0.64) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E
SCHEMBL30032 0.79 PTGS2 (0.64) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E
SCHEMBL1155472 0.78 CYP2A6 (0.61) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E
SCHEMBL21110859 0.78 CYP2A6 (0.67) CYP2A6ALDH1A1CYP3A4CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2566858-A2 HETEROCYCLIC DERIVATIVES AS ALK INHIBITORS Pfizer Inc. (US) 2013-03-13 EP disclosed
WO-2011138751-A2 HETEROCYCLIC DERIVATIVES AS ALK INHIBITORS PFIZER INC. (US) 2011-11-10 WO disclosed